Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 56, Issue 1

Issues

Next generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma

Said El Shamieh
  • Corresponding author
  • Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Fatima Saleh
  • Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mirna A. Fawaz / Gérard Siest
  • UMR INSERM U1122; IGE-PCV ‘Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire’, Université de Lorraine, Nancy, France
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Fadi S. Farhat / Sophie Visvikis-Siest
  • UMR INSERM U1122; IGE-PCV ‘Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire’, Université de Lorraine, Nancy, France
  • Department of Internal Medicine and Geriatrics, CHU Technopôle Nancy-Brabois, Vandoeuvre-lès-Nancy, France
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2017-06-29 | DOI: https://doi.org/10.1515/cclm-2017-0208

References

  • 1.

    McGuire S. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Adv Nutr 2016;7:418–9.CrossrefWeb of SciencePubMedGoogle Scholar

  • 2.

    Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10–7.CrossrefPubMedGoogle Scholar

  • 3.

    Han SY, Kato H, Kato S, Suzuki T, Shibata H, Ishii S, et al. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay. Cancer Res 2000;60:3147–51.PubMedGoogle Scholar

  • 4.

    Rudd ML, Price JC, Fogoros S, Godwin AK, Sgroi DC, Merino MJ, et al. A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas. Clin Cancer Res 2011;17:1331–40.CrossrefPubMedGoogle Scholar

  • 5.

    Janku F, Wheler JJ, Naing A, Falchook GS, Hong DS, Stepanek VM, et al. PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials. Cancer Res 2013;73:276–84.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 6.

    Bluteau O, Jeannot E, Bioulac-Sage P, Marques JM, Blanc JF, Bui H, et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002;32:312–5.CrossrefPubMedGoogle Scholar

  • 7.

    Bilbao C, Rodriguez G, Ramirez R, Falcon O, Leon L, Chirino R, et al. The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer. Int J Cancer 2006;119:563–70.PubMedCrossrefGoogle Scholar

  • 8.

    Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356–62.CrossrefPubMedGoogle Scholar

  • 9.

    Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 2015;372:2509–20.PubMedCrossrefGoogle Scholar

  • 10.

    Mehnert JM, Panda A, Zhong H, Hirshfield K, Damare S, Lane K, et al. Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer. J Clin Invest 2016;126:2334–40.PubMedCrossrefWeb of ScienceGoogle Scholar

About the article

Corresponding author: Said El Shamieh, PhD, Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, P.O. Box: 11 5020 Beirut, Lebanon, Phone: +961 1 300110 Ext: 2721

Said El Shamieh and Fatima Saleh contributed equally to this work


Received: 2017-03-09

Accepted: 2017-05-29

Published Online: 2017-06-29

Published in Print: 2017-11-27


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 56, Issue 1, Pages e19–e22, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2017-0208.

Export Citation

©2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Supplementary Article Materials

Comments (0)

Please log in or register to comment.
Log in